- Home
- NAVI vs DYN Comparison
NAVI vs DYN Comparison
Compare NAVI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAVI
- DYN
- Stock Information
- Founded
- NAVI 1973
- DYN 1984
- Country
- NAVI United States
- DYN United States
- Employees
- NAVI N/A
- DYN N/A
- Industry
- NAVI Investment Bankers/Brokers/Service
- DYN Medicinal Chemicals and Botanical Products
- Sector
- NAVI Finance
- DYN Health Care
- Exchange
- NAVI Nasdaq
- DYN Nasdaq
- Market Cap
- NAVI 1.4B
- DYN 1.4B
- IPO Year
- NAVI N/A
- DYN 2020
- Fundamental
- Price
- NAVI $14.82
- DYN $8.70
- Analyst Decision
- NAVI Hold
- DYN Strong Buy
- Analyst Count
- NAVI 7
- DYN 15
- Target Price
- NAVI $13.64
- DYN $43.60
- AVG Volume (30 Days)
- NAVI 658.7K
- DYN 3.4M
- Earning Date
- NAVI 07-23-2025
- DYN 08-11-2025
- Dividend Yield
- NAVI 4.32%
- DYN N/A
- EPS Growth
- NAVI N/A
- DYN N/A
- EPS
- NAVI 0.52
- DYN N/A
- Revenue
- NAVI $699,000,000.00
- DYN N/A
- Revenue This Year
- NAVI N/A
- DYN N/A
- Revenue Next Year
- NAVI $2.85
- DYN N/A
- P/E Ratio
- NAVI $28.59
- DYN N/A
- Revenue Growth
- NAVI N/A
- DYN N/A
- 52 Week Low
- NAVI $10.53
- DYN $6.36
- 52 Week High
- NAVI $16.97
- DYN $47.45
- Technical
- Relative Strength Index (RSI)
- NAVI 69.14
- DYN 29.87
- Support Level
- NAVI $13.25
- DYN $8.41
- Resistance Level
- NAVI $14.44
- DYN $10.74
- Average True Range (ATR)
- NAVI 0.35
- DYN 0.77
- MACD
- NAVI 0.10
- DYN -0.39
- Stochastic Oscillator
- NAVI 92.47
- DYN 5.62
About NAVI Navient Corporation
Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in three segments: Federal Education Loans, Consumer Lending, and Business Processing. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.